Calyx Medical Imaging: Future-focused for Oncology Trial Success
The success of your oncology treatment development program may come down to the reliability of your imaging provider. You need confidence in their experience and their ability to keep up with the ever-changing challenges of oncology trial imaging.
While at ASCO, visit Booth 10098 to meet with some of Calyx’s 80 in-house scientists, technicians, and imaging experts. They are immersed in scientific advances, evolving modalities/criteria, and constantly changing regulations that could impact your oncology development program.
Calyx Medical Imaging has successfully supported over 1,700 solid tumor and hematology trials, including those exploring novel treatments such as TIL, ADC, CAR-T, radioligand, and gene therapies.
Stop by to learn how we combine this experience with current oncology trial best practices to implement an imaging strategy that’s future-focused to meet your development objectives.
